( April 17, 2026, 11:46 AM EDT) -- PHILADELPHIA — A Third Circuit U.S. Court of Appeals panel affirmed a New Jersey federal judge’s denial of a preliminary injunction requested by appellants Johnson & Johnson and Janssen Biotech Inc., agreeing that the appellants had failed to show irreparable harm caused through Samsung Bioepis Co. Ltd. by an alleged breach of the settlement in an earlier patent dispute....